Intelligene
智新生技股份有限公司
Intelligene is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| IG-001 | siRNA | Preclinical studies ongoing | COVID-19 | — | 2026-07-16 | Company disclosure |
| IG-002 | siRNA | Preclinical studies ongoing | Influenza | — | 2026-07-16 | Company disclosure |
Key events
- Gold Coast research-center and Griffith University collaboration update (company disclosure)